- Home
- ELTK vs CTMX Comparison
ELTK vs CTMX Comparison
Compare ELTK & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTK
- CTMX
- Stock Information
- Founded
- ELTK 1970
- CTMX 2008
- Country
- ELTK Israel
- CTMX United States
- Employees
- ELTK N/A
- CTMX N/A
- Industry
- ELTK Electrical Products
- CTMX Biotechnology: Pharmaceutical Preparations
- Sector
- ELTK Technology
- CTMX Health Care
- Exchange
- ELTK Nasdaq
- CTMX Nasdaq
- Market Cap
- ELTK 73.9M
- CTMX 62.3M
- IPO Year
- ELTK 1997
- CTMX 2015
- Fundamental
- Price
- ELTK $11.14
- CTMX $0.78
- Analyst Decision
- ELTK
- CTMX Buy
- Analyst Count
- ELTK 0
- CTMX 6
- Target Price
- ELTK N/A
- CTMX $5.77
- AVG Volume (30 Days)
- ELTK 10.9K
- CTMX 688.7K
- Earning Date
- ELTK 03-10-2025
- CTMX 03-10-2025
- Dividend Yield
- ELTK 1.98%
- CTMX N/A
- EPS Growth
- ELTK N/A
- CTMX N/A
- EPS
- ELTK 0.85
- CTMX 0.16
- Revenue
- ELTK $48,090,000.00
- CTMX $126,617,000.00
- Revenue This Year
- ELTK $7.47
- CTMX $22.55
- Revenue Next Year
- ELTK $9.96
- CTMX N/A
- P/E Ratio
- ELTK $13.10
- CTMX $4.83
- Revenue Growth
- ELTK 7.22
- CTMX 33.66
- 52 Week Low
- ELTK $9.00
- CTMX $0.75
- 52 Week High
- ELTK $14.52
- CTMX $5.85
- Technical
- Relative Strength Index (RSI)
- ELTK 47.59
- CTMX 40.63
- Support Level
- ELTK $11.05
- CTMX $0.77
- Resistance Level
- ELTK $11.60
- CTMX $0.83
- Average True Range (ATR)
- ELTK 0.40
- CTMX 0.06
- MACD
- ELTK -0.01
- CTMX 0.00
- Stochastic Oscillator
- ELTK 54.90
- CTMX 13.04
About ELTK Eltek Ltd.
Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnects. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.